These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 32564483)

  • 1. The Microbiome and Hepatocellular Carcinoma.
    Rattan P; Minacapelli CD; Rustgi V
    Liver Transpl; 2020 Oct; 26(10):1316-1327. PubMed ID: 32564483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut Microbiome and Hepatocellular Carcinoma.
    Akkız H
    J Gastrointest Cancer; 2021 Dec; 52(4):1314-1319. PubMed ID: 34870783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
    Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
    Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical immunometabolism and metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome.
    Golonka RM; Vijay-Kumar M
    Adv Cancer Res; 2021; 149():171-255. PubMed ID: 33579424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.
    Song Y; Lau HC; Zhang X; Yu J
    Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the temporal evolution of gut dysbiosis and inflammatory responses leading to hepatocellular carcinoma in Mdr2 -/- mouse model.
    Behary J; Raposo AE; Amorim NML; Zheng H; Gong L; McGovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson MT; Seet-Lee J; McCaughan GW; El-Omar EM; Zekry A
    BMC Microbiol; 2021 Apr; 21(1):113. PubMed ID: 33858327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiome-bile acid axis in hepatocarcinogenesis.
    Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
    Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiome and liver cancer: mechanisms and clinical translation.
    Yu LX; Schwabe RF
    Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota: A new piece in understanding hepatocarcinogenesis.
    Zhou A; Tang L; Zeng S; Lei Y; Yang S; Tang B
    Cancer Lett; 2020 Apr; 474():15-22. PubMed ID: 31917160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights and therapeutic implication of gut microbiota in non-alcoholic fatty liver disease and its associated liver cancer.
    Ezzaidi N; Zhang X; Coker OO; Yu J
    Cancer Lett; 2019 Sep; 459():186-191. PubMed ID: 31185249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
    Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
    Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human microbiome is a diagnostic biomarker in hepatocellular carcinoma.
    Rao BC; Lou JM; Wang WJ; Li A; Cui GY; Yu ZJ; Ren ZG
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):109-115. PubMed ID: 32037278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions.
    Rajapakse J; Khatiwada S; Akon AC; Yu KL; Shen S; Zekry A
    Gut Microbes; 2023 Dec; 15(2):2240031. PubMed ID: 37615334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling.
    Li Z; Zhang Y; Hong W; Wang B; Chen Y; Yang P; Zhou J; Fan J; Zeng Z; Du S
    Gut Microbes; 2022; 14(1):2119055. PubMed ID: 36093568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
    Jiang JW; Chen XH; Ren Z; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Gut Microbiota in Hepatocarcinogenesis.
    Gupta H; Youn GS; Shin MJ; Suk KT
    Microorganisms; 2019 May; 7(5):. PubMed ID: 31060311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
    Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma.
    Acharya S; Thirunavukkarasu C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):67. PubMed ID: 38420824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular Cancer and Gut Microbiome: Time to Untie Gordian's Knot.
    Aygün C; Tözün N
    J Gastrointest Cancer; 2021 Dec; 52(4):1309-1313. PubMed ID: 34750696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.